Quidel PE Ratio 2006-2019 | QDEL

Current and historical p/e ratio for Quidel (QDEL) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Quidel PE ratio as of January 23, 2020 is 30.33.
Quidel PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-01-24 78.02 43.59
2019-09-30 61.35 $1.79 34.27
2019-06-30 59.32 $1.68 35.31
2019-03-31 65.47 $1.57 41.70
2018-12-31 48.82 $1.83 26.68
2018-09-30 65.17 $0.90 72.41
2018-06-30 66.50 $0.47 141.49
2018-03-31 51.81 $0.20 259.05
2017-12-31 43.35 $-0.24 0.00
2017-09-30 43.86 $-0.15 0.00
2017-06-30 27.14 $-0.01 0.00
2017-03-31 22.64 $0.10 226.40
2016-12-31 21.42 $-0.43 0.00
2016-09-30 22.09 $-0.38 0.00
2016-06-30 17.86 $-0.38 0.00
2016-03-31 17.26 $-0.40 0.00
2015-12-31 21.20 $-0.18 0.00
2015-09-30 18.88 $0.03 629.33
2015-06-30 22.95 $-0.12 0.00
2015-03-31 26.98 $-0.06 0.00
2014-12-31 28.92 $-0.21 0.00
2014-09-30 26.87 $-0.38 0.00
2014-06-30 22.11 $-0.34 0.00
2014-03-31 27.30 $-0.19 0.00
2013-12-31 30.89 $0.21 147.10
2013-09-30 28.40 $0.44 64.55
2013-06-30 25.53 $0.55 46.42
2013-03-31 23.75 $0.50 47.50
2012-12-31 18.67 $0.14 133.36
2012-09-30 18.93 $-0.09 0.00
2012-06-30 15.68 $-0.10 0.00
2012-03-31 18.37 $-0.11 0.00
2011-12-31 15.13 $0.24 63.04
2011-09-30 16.37 $0.20 81.85
2011-06-30 15.15 $0.02 757.50
2011-03-31 11.96 $0.04 299.00
2010-12-31 14.45 $-0.40 0.00
2010-09-30 10.99 $0.28 39.25
2010-06-30 12.69 $0.99 12.82
2010-03-31 14.54 $1.10 13.22
2009-12-31 13.78 $1.10 12.53
2009-09-30 16.23 $0.62 26.18
2009-06-30 14.56 $0.27 53.93
2009-03-31 9.22 $0.23 40.09
2008-12-31 13.07 $0.58 22.53
2008-09-30 16.41 $0.64 25.64
2008-06-30 16.54 $0.56 29.54
2008-03-31 16.06 $0.53 30.30
2007-12-31 19.47 $0.41 47.49
2007-09-30 19.56 $0.70 27.94
2007-06-30 17.56 $0.69 25.45
2007-03-31 12.00 $0.62 19.35
2006-12-31 13.62 $0.63 21.62
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.196B $0.522B
Quidel Corp. discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions that affect women's health throughout the phases of their lives including reproductive status, pregnancy management and osteoporosis. Quidel also provides point-of-care diagnostics for infectious diseases, including influenza A and B, strep throat, H. pylori infection, chlamydia and infectious mononucleosis.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $162.145B 22.40
Abbott Laboratories (ABT) United States $160.452B 28.00
Stryker (SYK) United States $80.889B 27.20
Boston Scientific (BSX) United States $60.729B 28.66
Baxter (BAX) United States $46.512B 28.20
EssilorLuxottica Societe Anonyme (ESLOY) France $33.852B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.752B 19.29
Lonza Group Ag (LZAGY) Switzerland $30.666B 0.00
Terumo (TRUMY) Japan $27.814B 34.71
Coloplast (CLPBY) Denmark $27.238B 42.03
ResMed (RMD) United States $23.206B 42.81
Smith & Nephew SNATS (SNN) United Kingdom $21.605B 0.00
Sunny Optical Technology (SNPTF) China $19.732B 0.00
Insulet (PODD) United States $11.870B 564.71
Bio-Rad Laboratories (BIO) United States $11.235B 53.93
Canopy Growth (CGC) Canada $8.566B 0.00
Perrigo (PRGO) Ireland $8.096B 15.10
William Demant Holdings (WILYY) Denmark $7.896B 0.00
Hill-Rom Holdings (HRC) United States $7.553B 22.21
DiaSorin S.p.A (DSRLF) Italy $7.357B 0.00
GN STORE NORD (GNNDY) Denmark $6.158B 31.81
Haemonetics (HAE) United States $5.578B 37.69
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
NuVasive (NUVA) United States $4.024B 31.68
ICU Medical (ICUI) United States $3.895B 25.39
Neogen (NEOG) United States $3.688B 61.38
GW Pharmaceuticals (GWPH) United Kingdom $3.580B 0.00
Agios Pharmaceuticals (AGIO) United States $3.136B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.086B 0.00
National Vision Holdings (EYE) United States $2.814B 63.52
Aurora Cannabis (ACB) Canada $2.255B 0.00
Cardiovascular Systems (CSII) United States $1.860B 0.00
InMode (INMD) Israel $1.591B 0.00
AtriCure (ATRC) United States $1.483B 0.00
Aphria (APHA) $1.455B 0.00
TG Therapeutics (TGTX) United States $1.349B 0.00
VAREX IMAGING (VREX) United States $1.191B 23.81
NanoString Technologies (NSTG) United States $1.058B 0.00
Phibro Animal Health (PAHC) United States $1.042B 19.51
PetIQ (PETQ) United States $0.869B 21.19
Eagle Pharmaceuticals (EGRX) United States $0.793B 30.36
Lantheus Holdings (LNTH) United States $0.739B 18.45
LeMaitre Vascular (LMAT) United States $0.733B 41.20
Quanterix (QTRX) United States $0.721B 0.00
Omeros (OMER) United States $0.682B 0.00
Cerus (CERS) United States $0.629B 0.00
Surmodics (SRDX) United States $0.562B 58.24
MacroGenics (MGNX) United States $0.558B 0.00
OraSure Technologies (OSUR) United States $0.509B 30.52
Organigram Holdings (OGI) Canada $0.472B 0.00
Owens & Minor (OMI) United States $0.420B 15.56
Meridian Bioscience (VIVO) United States $0.412B 14.15
HEXO (HEXO) $0.408B 0.00
Utah Medical Products (UTMD) United States $0.384B 27.84
Zynex (ZYXI) United States $0.341B 38.59
BioLife Solutions (BLFS) United States $0.317B 129.00
Bovie Medical (APYX) United States $0.281B 0.00
Female Health (VERU) United States $0.279B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.270B 0.00
Vapotherm (VAPO) United States $0.244B 0.00
Repro-Med Systems (KRMD) United States $0.227B 0.00
United Health Products (UEEC) United States $0.222B 0.00
Viemed Healthcare (VMD) United States $0.217B 22.92
Liberty Health Sciences (LHSIF) Canada $0.184B 0.00
InfuSystems Holdings (INFU) United States $0.171B 863.00
Green Organic Dutchman Holdings (TGODF) Canada $0.169B 0.00
Rockwell Medical (RMTI) United States $0.166B 0.00
Cytosorbents (CTSO) United States $0.152B 0.00
Fonar (FONR) United States $0.134B 9.42
Chimerix (CMRX) United States $0.122B 0.00
MTech Acquisition (KERN) United States $0.102B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
Surface Oncology (SURF) United States $0.091B 0.00
United-Guardian (UG) United States $0.082B 20.65
MRI Interventions (MRIC) United States $0.079B 0.00
Nephros (NEPH) United States $0.076B 0.00
Chembio Diagnostics (CEMI) United States $0.070B 0.00
FSD PHARMA INC (HUGE) $0.051B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.035B 0.00
GUARDION HEALTH (GHSI) United States $0.024B 0.00
NF Energy Saving (BIMI) China $0.024B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.014B 0.00
Senestech (SNES) United States $0.013B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Valeritas Holdings (VLRX) United States $0.006B 0.00
Myomo (MYO) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00